Literature DB >> 18520187

Nasal pepsin assay and pH monitoring in chronic rhinosinusitis.

Süay Ozmen1, Omer Taskin Yücel, Incilkay Sinici, Omer Afsin Ozmen, Ahmet Emre Süslü, Oğuz Oğretmenoğlu, Metin Onerci.   

Abstract

OBJECTIVES/HYPOTHESIS: The primary objective of this study was to determine the relationship between chronic rhinosinusitis (CRS) and laryngopharyngeal reflux (LPR). We also investigated the diagnostic value of pepsin in nasal lavage by means of fluorometric assay as compared with 24-hour dual-probe pH monitoring. STUDY DESIGN AND METHODS: This is a controlled, prospective study from a retrospective dataset of 33 patients recruited for endoscopic sinus surgery between 2005 and 2006 in a tertiary care referral center (Hacettepe University Medical Center). All patients underwent 24-hour dual-probe pH monitoring and nasal lavage fluid investigation for pepsin. A fluorometric pepsin assay using casein-fluorescein isothiocyanate in nasal lavage fluid was used to detect LPR. The control group included 20 patients who were proven not to have sinusitis.
RESULTS: A higher incidence of pharyngeal acid reflux events was found in patients with CRS (29 of 33, 88%) compared with the control patients (11 of 20, 55%). The difference was statistically significant (P = .01). The fluorometric pepsin assay was correlated to the results of 24-hour dual-probe monitoring for LPR diagnosis with a 100% sensitivity and 92.5% specificity. These data suggest that an association between CRS and LPR is present and that the detection of pepsin in nasal lavage fluid may provide a noninvasive and feasible method of LPR screening.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520187     DOI: 10.1097/MLG.0b013e318165e324

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  14 in total

Review 1.  How to Assess, Control, and Manage Uncontrolled CRS/Nasal Polyp Patients.

Authors:  Rahuram Sivasubramaniam; Richard J Harvey
Journal:  Curr Allergy Asthma Rep       Date:  2017-09       Impact factor: 4.806

Review 2.  Oropharyngeal Reflux Monitoring and Atypical Gastroesophageal Reflux Disease.

Authors:  Dhyanesh A Patel; Ali H Harb; Michael F Vaezi
Journal:  Curr Gastroenterol Rep       Date:  2016-03

Review 3.  Extra-esophageal manifestations of GERD: who responds to GERD therapy?

Authors:  Rishi D Naik; Michael F Vaezi
Journal:  Curr Gastroenterol Rep       Date:  2013-04

Review 4.  Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment.

Authors:  Christopher Hom; Michael F Vaezi
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

5.  [Pharyngeal acid load and different functional endoscopy findings].

Authors:  F Michel; R Dannesberger; T Stroh; R Fritsche; P Ahrens
Journal:  HNO       Date:  2019-12       Impact factor: 1.284

6.  [Importance of functional endoscopy for diagnostics of extraesophageal reflux : relationship of Belafsky's reflux symptom index and functional endoscopic data].

Authors:  F Michel; R Dannesberger; R Fritsche; T Stroh; P Ahrens
Journal:  HNO       Date:  2014-11       Impact factor: 1.284

7.  Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.

Authors:  Cezmi A Akdis; Claus Bachert; Cemal Cingi; Mark S Dykewicz; Peter W Hellings; Robert M Naclerio; Robert P Schleimer; Dennis Ledford
Journal:  J Allergy Clin Immunol       Date:  2013-04-12       Impact factor: 10.793

8.  New developments in extraesophageal reflux disease.

Authors:  Elif Saritas Yuksel; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-09

Review 9.  Gastroesophageal reflux and rhinosinusitis.

Authors:  Elin-Johanne Katle; Jan G Hatlebakk; Sverre Steinsvåg
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

Review 10.  Laryngopharyngeal reflux and Helicobacter pylori.

Authors:  Taner Yılmaz; Münir Demir Bajin; Rıza Önder Günaydın; Serdar Ozer; Tevfik Sözen
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.